You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MYD88 mutation

Showing 1 - 25 of 2,916
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
Apr 1, 2022

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Washington, District of Columbia
  • +5 more
Nov 29, 2022

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022

Non-GCB/ABC DLBCL, With and Without MyD88 and/or CD79B Mutations Trial in Cleveland, Toledo (Mivavotinib)

Recruiting
  • Non-GCB/ABC Diffuse Large B-Cell Lymphoma
  • With and Without MyD88 and/or CD79B Mutations
  • Evanston, Illinois
  • +6 more
Dec 12, 2022

Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • (no location specified)
Nov 28, 2022

Waldenstrom Macroglobulinemia Trial in Austria, Germany, Greece (Carfilzomib + Ibrutinib, Ibrutinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Salzburg, Austria
  • +16 more
Mar 11, 2022

Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • B-Cell Lymphoproliferative Disorder
  • Boston, Massachusetts
  • +2 more
Feb 18, 2023

Waldenstrom's Disease, Prognostic Index Trial in France

Not yet recruiting
  • Waldenstrom's Disease
  • Prognostic Index
    • Amiens, France
    • +14 more
    Jun 12, 2023

    Diffuse Large B Cell Lymphoma Trial in Shanghai (zanubrutinib)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 13, 2022

    Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 1, 2022

    MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • MRD and clonal evolution
    • Milano, MI, Italy
    • +13 more
    Nov 2, 2022

    Diffuse Large B-cell Lymphoma Trial in Switzerland (Acalabrutinib)

    Recruiting
    • Diffuse Large B-cell Lymphoma
    • Bergamo, Italy
    • +16 more
    Jan 17, 2023

    Waldenstrom's Disease Trial in Rouen (Determination of mutation)

    Unknown status
    • Waldenstrom's Disease
    • Determination of mutation
    • Rouen, France
      Centre Henri Becquerel
    Jul 29, 2020

    ASO and Beta-hemolytic Group A Streptococcus Infections in

    Unknown status
    • Attention Deficit-Hyperactivity Disorder
    • Antistreptolysin O Test
    • +3 more
    • Orbassano, Torino, Italy
      AOU San Luigi Gonzaga di Orbassano
    Mar 23, 2020

    Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

    Not yet recruiting
    • Monoclonal Gammopathy of Uncertain Significance
    • Zanubrutinib Oral Product
    • Utrecht, Netherlands
      University Medical Center Utrecht
    Jul 6, 2023

    GATA2 Gene Mutation Trial in France (Biological samples (blood and bone marrow samples).)

    Not yet recruiting
    • GATA2 Gene Mutation
    • Biological samples (blood and bone marrow samples).
    • Angers, France
    • +16 more
    Jul 31, 2023

    Relapsed or Refractory Follicular Lymphoma With Enhancer of

    Recruiting
    • Lymphoma, Follicular
    • Anjo-shi, Aichi, Japan
    • +174 more
    Dec 12, 2022

    Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation Trial in Zhengzhou (Rituximab, Zanubrutinib,

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
    Jan 22, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

    Active, not recruiting
    Has Results
    • Non Small Cell Lung Cancer
    • La Jolla, California
    • +43 more
    Nov 25, 2022

    Genetic and Functional Analysis of Cherubism

    Recruiting
    • Cherubism
      • Farmington, Connecticut
        University of Connecticut Health Center
      Jan 24, 2022

      Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)

      Not yet recruiting
      • Waldenstrom Macroglobulinemia
      • Venetoclax; Rituximab
      • DRC
      • (no location specified)
      Nov 4, 2022

      Waldenstrom's Disease, Waldenstrom Macroglobulinemia Trial in Amiens (bone marrow sample, blood sample)

      Recruiting
      • Waldenstrom's Disease
      • Waldenstrom Macroglobulinemia
      • bone marrow sample
      • blood sample
      • Amiens, France
        CHU Amiens
      May 17, 2021

      Metastatic Colorectal Cancer, BRAF V600E Mutation Positive Trial in France (Collection of blood samples)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • BRAF V600E Mutation Positive
      • Collection of blood samples
      • Avignon, France
      • +26 more
      Nov 25, 2022

      Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

      Recruiting
      • Retinitis Pigmentosa
      • +4 more
        • San Francisco, California
        • +4 more
        Oct 5, 2022

        NSCLC Trial in Australia, China, Korea, Republic of (AZD9291)

        Active, not recruiting
        Has Results
        • Non-Small Cell Lung Cancer
        • Kogarah, Australia
        • +29 more
        Oct 20, 2022